Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience / Pouillon, L; Baumann, C; Rousseau, H; Choukour, M; Andrianjafy, C; Danese, S; Peyrin-Biroulet, L. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 25:5(2019), pp. 945-954. [10.1093/ibd/izy322]
Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience
Danese S;
2019-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.